memantine has been researched along with Fibromyalgia in 6 studies
Fibromyalgia: A common nonarticular rheumatic syndrome characterized by myalgia and multiple points of focal muscle tenderness to palpation (trigger points). Muscle pain is typically aggravated by inactivity or exposure to cold. This condition is often associated with general symptoms, such as sleep disturbances, fatigue, stiffness, HEADACHES, and occasionally DEPRESSION. There is significant overlap between fibromyalgia and the chronic fatigue syndrome (FATIGUE SYNDROME, CHRONIC). Fibromyalgia may arise as a primary or secondary disease process. It is most frequent in females aged 20 to 50 years. (From Adams et al., Principles of Neurology, 6th ed, p1494-95)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficacy of memantine on metabolite levels in different areas of the brain and to determine whether changes in metabolite levels correlate with clinical variables in Fibromyalgia (FM) patients." | 9.19 | Changes in metabolites after treatment with memantine in fibromyalgia. A double-blind randomized controlled trial with magnetic resonance spectroscopy with a 6-month follow-up. ( Andrés, E; Fayed, N; Garcia-Campayo, J; Herrera-Mercadal, P; López del Hoyo, Y; Magallon, R; Olivan-Blázquez, B; Pérez-Yus, MC; Puebla-Guedea, M; Viguera, L, 2014) |
| "MEDLINE, EMBASE and CENTRAL databases were searched for comparative trials using memantine, either against placebo or active medications, for chronic pain in adults." | 9.01 | A systematic review and meta-analysis of memantine for the prevention or treatment of chronic pain. ( Kurian, R; Raza, K; Shanthanna, H, 2019) |
| "We have recently reported that memantine has a clinically relevant antimanic and long-lasting mood-stabilizing effect in treatment-resistant bipolar disorders, both as augmenting agent and as monotherapy." | 7.80 | Memantine in the treatment and prophylaxis of bipolar II disorder and comorbid fibromyalgia: a case report. ( DE Chiara, L; Kahn, DA; Koukopoulos, A; Koukopoulos, AE; Serra, G, 2014) |
| "Memantine was administered at doses of 20mg/d after 1 month of titration." | 6.79 | Efficacy of memantine in the treatment of fibromyalgia: A double-blind, randomised, controlled trial with 6-month follow-up. ( Andrés, E; Fayed, N; Garcia-Campayo, J; Herrera-Mercadal, P; López-Del-Hoyo, Y; Magallon, R; Olivan-Blázquez, B; Pérez-Yus, MC; Puebla-Guedea, M; Roca, M, 2014) |
| "Fibromyalgia is a prevalent chronic rheumatic disease of great clinical importance." | 6.78 | Evaluation of the efficacy of memantine in the treatment of fibromyalgia: study protocol for a doubled-blind randomized controlled trial with six-month follow-up. ( Andrés, E; Arcega, R; Garcia-Campayo, J; López-del-Hoyo, Y; Magallon, R; Masluk, B; Olivan-Blázquez, B; Pérez-Yus, MC; Puebla, M; Roca, M, 2013) |
| "To evaluate the efficacy of memantine on metabolite levels in different areas of the brain and to determine whether changes in metabolite levels correlate with clinical variables in Fibromyalgia (FM) patients." | 5.19 | Changes in metabolites after treatment with memantine in fibromyalgia. A double-blind randomized controlled trial with magnetic resonance spectroscopy with a 6-month follow-up. ( Andrés, E; Fayed, N; Garcia-Campayo, J; Herrera-Mercadal, P; López del Hoyo, Y; Magallon, R; Olivan-Blázquez, B; Pérez-Yus, MC; Puebla-Guedea, M; Viguera, L, 2014) |
| "MEDLINE, EMBASE and CENTRAL databases were searched for comparative trials using memantine, either against placebo or active medications, for chronic pain in adults." | 5.01 | A systematic review and meta-analysis of memantine for the prevention or treatment of chronic pain. ( Kurian, R; Raza, K; Shanthanna, H, 2019) |
| "We have recently reported that memantine has a clinically relevant antimanic and long-lasting mood-stabilizing effect in treatment-resistant bipolar disorders, both as augmenting agent and as monotherapy." | 3.80 | Memantine in the treatment and prophylaxis of bipolar II disorder and comorbid fibromyalgia: a case report. ( DE Chiara, L; Kahn, DA; Koukopoulos, A; Koukopoulos, AE; Serra, G, 2014) |
| "Memantine was administered at doses of 20mg/d after 1 month of titration." | 2.79 | Efficacy of memantine in the treatment of fibromyalgia: A double-blind, randomised, controlled trial with 6-month follow-up. ( Andrés, E; Fayed, N; Garcia-Campayo, J; Herrera-Mercadal, P; López-Del-Hoyo, Y; Magallon, R; Olivan-Blázquez, B; Pérez-Yus, MC; Puebla-Guedea, M; Roca, M, 2014) |
| "Fibromyalgia is a prevalent chronic rheumatic disease of great clinical importance." | 2.78 | Evaluation of the efficacy of memantine in the treatment of fibromyalgia: study protocol for a doubled-blind randomized controlled trial with six-month follow-up. ( Andrés, E; Arcega, R; Garcia-Campayo, J; López-del-Hoyo, Y; Magallon, R; Masluk, B; Olivan-Blázquez, B; Pérez-Yus, MC; Puebla, M; Roca, M, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kurian, R | 1 |
| Raza, K | 1 |
| Shanthanna, H | 1 |
| Serra, G | 2 |
| DE Chiara, L | 1 |
| Koukopoulos, AE | 1 |
| Koukopoulos, A | 1 |
| Kahn, DA | 1 |
| Olivan-Blázquez, B | 3 |
| Herrera-Mercadal, P | 2 |
| Puebla-Guedea, M | 2 |
| Pérez-Yus, MC | 3 |
| Andrés, E | 3 |
| Fayed, N | 2 |
| López-Del-Hoyo, Y | 2 |
| Magallon, R | 3 |
| Roca, M | 2 |
| Garcia-Campayo, J | 3 |
| López del Hoyo, Y | 1 |
| Viguera, L | 1 |
| Recla, JM | 1 |
| Sarantopoulos, CD | 1 |
| Puebla, M | 1 |
| Masluk, B | 1 |
| Arcega, R | 1 |
1 review available for memantine and Fibromyalgia
| Article | Year |
|---|---|
A systematic review and meta-analysis of memantine for the prevention or treatment of chronic pain.
Topics: Adult; Analgesics; Chronic Pain; Fibromyalgia; Humans; Memantine; Receptors, N-Methyl-D-Aspartate | 2019 |
3 trials available for memantine and Fibromyalgia
| Article | Year |
|---|---|
Efficacy of memantine in the treatment of fibromyalgia: A double-blind, randomised, controlled trial with 6-month follow-up.
Topics: Adult; Cognition Disorders; Double-Blind Method; Excitatory Amino Acid Antagonists; Female; Fibromya | 2014 |
Changes in metabolites after treatment with memantine in fibromyalgia. A double-blind randomized controlled trial with magnetic resonance spectroscopy with a 6-month follow-up.
Topics: Adult; Aspartic Acid; Brain; Creatine; Dopamine Agents; Double-Blind Method; Female; Fibromyalgia; F | 2014 |
Evaluation of the efficacy of memantine in the treatment of fibromyalgia: study protocol for a doubled-blind randomized controlled trial with six-month follow-up.
Topics: Brain; Clinical Protocols; Cognition; Double-Blind Method; Drug Administration Schedule; Excitatory | 2013 |
2 other studies available for memantine and Fibromyalgia
| Article | Year |
|---|---|
Memantine in the treatment and prophylaxis of bipolar II disorder and comorbid fibromyalgia: a case report.
Topics: Bipolar Disorder; Diagnostic and Statistical Manual of Mental Disorders; Dopamine Agents; Female; Fi | 2014 |
Combined use of pregabalin and memantine in fibromyalgia syndrome treatment: a novel analgesic and neuroprotective strategy?
Topics: Analgesics; Chronic Disease; Drug Therapy, Combination; Fibromyalgia; gamma-Aminobutyric Acid; Human | 2009 |